ArticleTranslational cancer research2018

Cost-effectiveness in managing skeletal related events in breast cancer: a strategy of less-intense dosing schedule of bone modifying agents.

Sri Harsha Tella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.